JP2005505569A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005505569A5 JP2005505569A5 JP2003528530A JP2003528530A JP2005505569A5 JP 2005505569 A5 JP2005505569 A5 JP 2005505569A5 JP 2003528530 A JP2003528530 A JP 2003528530A JP 2003528530 A JP2003528530 A JP 2003528530A JP 2005505569 A5 JP2005505569 A5 JP 2005505569A5
- Authority
- JP
- Japan
- Prior art keywords
- xylometazoline
- salt
- ipratropium
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101356 | 2001-09-18 | ||
| PCT/IB2002/003828 WO2003024433A2 (en) | 2001-09-18 | 2002-09-18 | Compositions for treatment of common cold, comprising ipratropium and xylometazoline |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005505569A JP2005505569A (ja) | 2005-02-24 |
| JP2005505569A5 true JP2005505569A5 (https=) | 2005-12-15 |
| JP4500045B2 JP4500045B2 (ja) | 2010-07-14 |
Family
ID=8160714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003528530A Expired - Lifetime JP4500045B2 (ja) | 2001-09-18 | 2002-09-18 | 感冒の治療のための組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7652030B2 (https=) |
| EP (2) | EP1446119B1 (https=) |
| JP (1) | JP4500045B2 (https=) |
| KR (1) | KR100810872B1 (https=) |
| CN (1) | CN1290502C (https=) |
| AT (1) | ATE318601T1 (https=) |
| BR (1) | BRPI0212586B8 (https=) |
| CA (1) | CA2460140C (https=) |
| DE (1) | DE60209511T2 (https=) |
| DK (1) | DK1446119T3 (https=) |
| EA (1) | EA008165B1 (https=) |
| ES (1) | ES2259098T3 (https=) |
| HU (1) | HU226527B1 (https=) |
| MX (1) | MXPA04002500A (https=) |
| NO (1) | NO334441B1 (https=) |
| NZ (1) | NZ531792A (https=) |
| PL (1) | PL208686B1 (https=) |
| PT (1) | PT1446119E (https=) |
| SI (1) | SI1446119T1 (https=) |
| WO (1) | WO2003024433A2 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| HU226527B1 (hu) * | 2001-09-18 | 2009-03-30 | Nycomed Danmark Aps | Készítmények nátha kezelésére |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| RU2006132043A (ru) * | 2004-02-06 | 2008-03-20 | МЕДА Фарма ГмбХ унд Ко.КГ (DE) | Комбинация и фармацевтический препарат для лечения ринита |
| WO2005084330A2 (en) * | 2004-03-02 | 2005-09-15 | Synergia Pharma, Inc. | Compositions and methods for treating nasal congestion |
| DE102004049008A1 (de) | 2004-10-05 | 2006-04-06 | Merck Patent Gmbh | Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur |
| JP2008525313A (ja) * | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
| DE102006023770A1 (de) * | 2006-05-20 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treibgasfreie Aerosolformulierung für die Inhalation |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20090270472A1 (en) * | 2008-04-25 | 2009-10-29 | Kenneth Gould | Method to use oxymetazoline to interrupt the development of the common cold syndrome |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| WO2010133294A2 (de) | 2009-05-18 | 2010-11-25 | Boehringer Ingelheim International Gmbh | Adapter, inhalationseinrichtung und zerstäuber |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EA026241B1 (ru) | 2009-11-25 | 2017-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Распылитель |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2014158118A1 (en) * | 2013-03-29 | 2014-10-02 | Santa Farma İlaç Sanayi̇ A.Ş. | Suspension composition containing ipratropium and oxymetazoline |
| WO2014158119A1 (en) * | 2013-03-29 | 2014-10-02 | Santa Farma İlaç Sanayi̇ A.Ş | Aqueous solution composition containing ipratropium and oxymetazoline |
| PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| WO2015054359A1 (en) * | 2013-10-08 | 2015-04-16 | Ebadi Mark A | Methods and compositions for symptomatic reflief of the common cold |
| HUE055604T2 (hu) | 2014-05-07 | 2021-12-28 | Boehringer Ingelheim Int | Porlasztó |
| AU2015257878B2 (en) | 2014-05-07 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
| EA035261B1 (ru) | 2014-05-07 | 2020-05-21 | Бёрингер Ингельхайм Интернациональ Гмбх | Небулайзер и контейнер |
| PL3236933T3 (pl) * | 2014-12-24 | 2019-05-31 | Jadran Galenski Laboratorij D D | Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość |
| MX383771B (es) * | 2015-12-02 | 2025-03-14 | Pablo Cortes Borrego | Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos. |
| US20220031739A1 (en) * | 2020-07-31 | 2022-02-03 | Eye Therapies Llc | Anti-viral compositions and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2122719A1 (en) * | 1991-11-19 | 1993-05-27 | Jack M. Gwaltney, Jr. | Combined virustatic antimediator (covam) treatment of common colds |
| IL101056A (en) | 1992-02-24 | 1997-03-18 | Res & Dev Co Ltd | Composition for nasal treatment |
| GB9218834D0 (en) | 1992-09-05 | 1992-10-21 | Procter & Gamble | Nasal spray products |
| SK280911B6 (sk) * | 1992-12-09 | 2000-09-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Farmaceutický prostriedok |
| EP0780127A1 (en) | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| DE19653969A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| JP2001524108A (ja) | 1997-04-30 | 2001-11-27 | ワーナー−ランバート・カンパニー | 局所経鼻抗炎症組成物 |
| DK1051155T3 (da) * | 1998-01-30 | 2002-09-16 | Novartis Consumer Health Sa | Nasale opløsninger |
| CN1161104C (zh) | 1998-06-18 | 2004-08-11 | 贝林格尔·英格海姆药物公司 | 有二种或多种活性物质的气溶胶药物制剂 |
| TR200103694T2 (tr) | 1999-06-22 | 2002-04-22 | Boehringer Ingelheim International Gmbh | Sabit ksilometazolin ve oksimetazolin çözeltisi |
| HU226527B1 (hu) * | 2001-09-18 | 2009-03-30 | Nycomed Danmark Aps | Készítmények nátha kezelésére |
-
2002
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
-
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
-
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005505569A5 (https=) | ||
| EP0036145B1 (en) | An orally administered drug form comprising a polar bioactive agent and an adjuvant | |
| US8450339B2 (en) | Compositions for treatment of common cold | |
| JP6158810B2 (ja) | ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス | |
| JP2003504368A5 (https=) | ||
| AU2023202420A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| CN102892418A (zh) | 含烟碱的药物组合物 | |
| AU2003243074A1 (en) | A buffered, liquid nicotine composition for pulmonary administration | |
| US20070020330A1 (en) | Compositions comprising azelastine and methods of use thereof | |
| JP2006506345A5 (https=) | ||
| CN102470099A (zh) | 儿童用奥洛他定鼻腔喷雾方案 | |
| KR20180030953A (ko) | 아젤라스틴을 포함하는 조성물 및 이의 사용 방법 | |
| CN100594936C (zh) | 改善透粘膜给药制剂的吸收的方法 | |
| JP2006505486A (ja) | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 | |
| WO2008013929A2 (en) | Anti-migraine oral spray formulations and methods | |
| CA2495275A1 (en) | Aerosol formulation for inhalation comprising an anticholinergic agent | |
| EP2978407B1 (en) | Aqueous solution composition containing ipratropium and oxymetazoline | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| KR20200121818A (ko) | 비강내 에피네프린 제제 및 질환의 치료 방법 | |
| SK12682003A3 (sk) | Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu | |
| US20050222205A1 (en) | Treatment of pain with ifendropil | |
| WO2014158118A1 (en) | Suspension composition containing ipratropium and oxymetazoline | |
| EP3525773A1 (en) | Nebulizable compositions of tiotropium and formoterol | |
| US20070293543A1 (en) | THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z | |
| WO2015054359A1 (en) | Methods and compositions for symptomatic reflief of the common cold |